Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

1.690 +0.060 (+3.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 732,511
Open 1.660
Bid (Size) 1.660 (4)
Ask (Size) 1.690 (106)
Prev. Close 1.630
Today's Range 1.640 - 1.720
52wk Range 0.9857 - 8.100
Shares Outstanding 31,355,723
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
FDA lifts REMS for approved CAR-T therapies, easing hospital restrictions and signaling broader future access in oncology and autoimmune treatment. 
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill

Performance

YTD
-27.5%
-27.5%
1 Month
-12.7%
-12.7%
3 Month
+56.5%
+56.5%
6 Month
-23.9%
-23.9%
1 Year
-78.5%
-78.5%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Looking Into Cabaletta Bio's Recent Short Interest
Via Benzinga
Top movers analysis in the middle of the day on 2025-06-11: top gainers and losers in today's session.
Via Chartmill
Which stocks are gapping on Wednesday?
Via Chartmill
Cabaletta Bio Announces Pricing of Public Offering of Securities
From Cabaletta Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Cabaletta Bio Announces Proposed Public Offering of Securities
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
From Cabaletta Bio
Via GlobeNewswire
Top movers in Friday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Cabaletta Bio Stock Surges To 2-Month High On Autoimmune Therapy Progress; Retail’s Pleased
Via Stocktwits
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform
From Cellares
Via Business Wire
Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
From Cabaletta Bio
Via GlobeNewswire
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025
From Cabaletta Bio
Via GlobeNewswire

Frequently Asked Questions

Is Cabaletta Bio, Inc. - Common Stock publicly traded?
Yes, Cabaletta Bio, Inc. - Common Stock is publicly traded.
What exchange does Cabaletta Bio, Inc. - Common Stock trade on?
Cabaletta Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cabaletta Bio, Inc. - Common Stock?
The ticker symbol for Cabaletta Bio, Inc. - Common Stock is CABA on the Nasdaq Stock Market
What is the current price of Cabaletta Bio, Inc. - Common Stock?
The current price of Cabaletta Bio, Inc. - Common Stock is 1.690
When was Cabaletta Bio, Inc. - Common Stock last traded?
The last trade of Cabaletta Bio, Inc. - Common Stock was at 07/16/25 04:00 PM ET
What is the market capitalization of Cabaletta Bio, Inc. - Common Stock?
The market capitalization of Cabaletta Bio, Inc. - Common Stock is 52.99M
How many shares of Cabaletta Bio, Inc. - Common Stock are outstanding?
Cabaletta Bio, Inc. - Common Stock has 53M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.